BYAKANGELICIN (b)
BYAKANGELICINa main furanocoumarin constituent isolated and characterized as an aldose reductase inhibitorand is effective for the treatment of sugar cataracts and diabetic neuropathy and hence might be useful as a lead compound for the development of new type drugs for clinical use.
Product Specifications
CAS Number
482-25-7
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
334.32
Molecular Formula
C17H18O7
Notes
Research use only, not for human use.
Receptor
Aldose reductase
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
